Pretreatment prediction of neoadjuvant chemotherapy response in HER-2 positive breast cancer patients using diffuse optical tomography imaging

Mirella L. Altoe, Alessandro Marone, Hyun K. Kim, Mariella Tejada, Hanina Hibshoosh, Hua Guo, Katherine D. Crew, Melissa K. Accordino, Meghna Trivedi, Kevin Kalinsky, Dawn L. Hershman, Andreas H. Hielscher

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    Abstract

    Normalized ctTHb levels measured prior to neoadjuvant chemotherapy can predict breast cancer response to NAC and potentially be used to improve personalized therapeutic strategies for HER-2 positive tumors.

    Original languageEnglish (US)
    Title of host publicationOptical Tomography and Spectroscopy, OTS 2020
    PublisherOSA - The Optical Society
    ISBN (Electronic)9781557528209
    DOIs
    StatePublished - 2020
    EventOptical Tomography and Spectroscopy, OTS 2020 - Washington, United States
    Duration: Apr 20 2020Apr 23 2020

    Publication series

    NameOptics InfoBase Conference Papers
    VolumePart F179-OTS-2020

    Conference

    ConferenceOptical Tomography and Spectroscopy, OTS 2020
    CountryUnited States
    City Washington
    Period4/20/204/23/20

    ASJC Scopus subject areas

    • Mechanics of Materials
    • Electronic, Optical and Magnetic Materials

    Fingerprint Dive into the research topics of 'Pretreatment prediction of neoadjuvant chemotherapy response in HER-2 positive breast cancer patients using diffuse optical tomography imaging'. Together they form a unique fingerprint.

    Cite this